ANGELINA PANFORD: Open Payments
NPI 1437698271 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 24 payments from 11 companies in 2025. Trend: 2023 $549 · 2024 $1,216 · 2025 $991
Food & beverage: $562Consulting: $380Education: $49
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $400 |
| Insulet Corporation | 8 | $284 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| Sumitomo Pharma America, Inc. | 1 | $56 |
| ABBVIE INC. | 2 | $45 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: Cologuard Collection Kit, Omnipod, CAPLYTA, INGREZZA, GEMTESA, MAVYRET, BEXSERO, VRAYLAR.
Industry payments across IN — which companies pay providers there.
